-
NPPA fixes ceiling prices of 355 medicines and 882 formulations
expresspharma
July 30, 2021
The authority fixes the ceiling prices of scheduled formulations as per the provisions of DPCO, 2013, and monitors the prices of non-scheduled drugs so as to ensure that their prices do not increase beyond 10 per cent in a year.
-
U.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVID-19
drugs
June 21, 2021
After spending billions to speed the creation of COVID-19 vaccines, the United States said Thursday that it will now devote $3.2 billion to the development of antiviral pills that could stop the new coronavirus before it does its worst damage.
-
Manufacturing capacity of Remdesivir ramped up to around 1.19 cr crore vials a month: Govt
expresspharma
May 19, 2021
The production capacity of remdesivir used for the treatment of COVID-19 has increased from 38 lakh vials per month to nearly 1.19 crore vials per month, the Ministry of Chemicals and Fertilizers said.
-
IDMA supports patent waiver for vaccines to ramp up production
expresspharma
May 14, 2021
Urges global pharma companies to grant voluntary licenses (VL) and transfer technology of vaccines to Indian companies against reasonable royalties.
-
Pharma firms not providing mandated quantity of Remdesivir to Maharashtra: Rajesh Tope
expresspharma
May 08, 2021
Maharashtra Health Minister Rajesh Tope alleged that most of the pharma companies are not supplying the mandated quantity of Remdesivir to the state.
-
NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment
expresspharma
May 07, 2021
Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19-positive patients.
-
PIL in HC seeks all remdesivir makers be allowed to sell it in domestic market
expresspharma
May 07, 2021
A bench issued notice to the health ministry, CDSCO, DGFT and various pharma companies, seeking their stand on the plea that claims only a handful of firms are allowed to sell the medicine in the domestic market.
-
Three-fold increase in remdesivir production in India: Mansukh Mandaviya
expresspharma
May 07, 2021
Production has gone up from 37 lakh on 12th April, 2021 to 1.05 crore on 4th May, 2021.
-
India to import 4.5 lakh vials of Remdesivir
expresspharma
May 06, 2021
The government has started importing the vital drug Remdesivir from other countries to ease its shortage in the country.
-
Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
worldpharmanews
April 28, 2021
When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.